Skip to main content
SpringerLink
Log in

Benefits of selenium in the treatment of depression and sleep disorders

Commentaries of the article “The selenium-containing compound 3-((4-chlorophenyl)selanyl)-1-methyl-1H-indole reverses depressive-like behavior induced by acute restraint stress in mice: modulation of oxido-nitrosative stress and inflammatory pathway”

  • Psychiatrics • Letter to the Editors
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Forceville X (2006) Seleno-enzymes and seleno-compounds: the two faces of selenium. Crit Care 10:180

    Article  PubMed  PubMed Central  Google Scholar 

  2. Casaril AM, Domingues M, Bampi SR et al (2019) The selenium-containing compound 3-((4-chlorophenyl)selanyl)-1-methyl-1H-indole reverses depressive-like behavior induced by acute restraint stress in mice: modulation of oxido-nitrosative stress and inflammatory pathway. Psychopharmacology In press

  3. Franzen PL, Buysse DJ (2008) Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci 10:473–481

    PubMed  PubMed Central  Google Scholar 

  4. Morris G, Stubbs B, Köhler CA, Walder K, Slyepchenko A, Berk M, Carvalho AF (2018) The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis. Sleep Med Rev 41:255–265

    Article  PubMed  Google Scholar 

  5. Benstoem C, Goetzenich A, Kraemer S, Borosch S, Manzanares W, Hardy G, Stoppe C (2015) Selenium and its supplementation in cardiovascular disease--what do we know? Nutrients. 7:3094–3118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Financial support

Our studies were financially supported by the Associacao Fundo de Incentivo a Pesquisa (AFIP) and the Sao Paulo Research Foundation (FAPESP, grant no. 2014/27329-5 for RGA). MLA and ST are recipients of CNPq fellowships.

Author information

Authors and Affiliations

  1. Department of Psychobiology, Universidade Federal de Sao Paulo, Rua Napoleao de Barros 925, Sao Paulo, SP, 04024-002, Brazil

    Rachel G. Albuquerque, Sergio Tufik & Monica L. Andersen

Authors
  1. Rachel G. Albuquerque
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sergio Tufik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Monica L. Andersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monica L. Andersen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Albuquerque, R.G., Tufik, S. & Andersen, M.L. Benefits of selenium in the treatment of depression and sleep disorders. Sleep Breath 23, 933–934 (2019). https://doi.org/10.1007/s11325-019-01816-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-019-01816-4

Search

Navigation